Synthetic Biologics, Inc. (NYSE: SYN) announced it has been awarded a contract by the Centers for Disease Control and Prevention ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE